Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02280876
What this trial is testing

Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Universidad Austral de Chile 30
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Testing effectiveness (Phase 2)Study completedNCT02097849
What this trial is testing

Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 71
Not applicableStudy completedNCT02474940
What this trial is testing

MS Symptom Management Study

Who this might be right for
Multiple SclerosisChronic PainFatigue
University of Washington 37
Post-approval studies (Phase 4)Active Not RecruitingNCT03535298
What this trial is testing

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
The Cleveland Clinic 800
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Not applicableStudy completedNCT04231253
What this trial is testing

MUltiple Sclerosis : T Cell / B Cell Exploration

Who this might be right for
Multiple Sclerosis
Rennes University Hospital 90
Not applicableStudy completedNCT04252053
What this trial is testing

The Effects of Pilates-Based Core Stabilization Training in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Istanbul University - Cerrahpasa 50
Post-approval studies (Phase 4)Looking for participantsNCT04480853
What this trial is testing

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 30
Very early researchLooking for participantsNCT07507201
What this trial is testing

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Not applicableStudy completedNCT06462339
What this trial is testing

The Effect of Online Pilates on Cognitive Function and Dual-Task Performance

Who this might be right for
Multiple Sclerosis
Gazi University 28
Not applicableStudy completedNCT01142583
What this trial is testing

A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 192
Not applicableActive Not RecruitingNCT06413602
What this trial is testing

The Synergistic Effects of AIH and FES in Persons With MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Shirley Ryan AbilityLab 40
Not applicableUnknownNCT04711941
What this trial is testing

A ToM Training for People With Multiple Sclerosis: an Efficacy Study.

Who this might be right for
Multiple Sclerosis
Fondazione Don Carlo Gnocchi ETS 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06843239
What this trial is testing

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Zura Bio Inc 80
Large-scale testing (Phase 3)Ended earlyNCT02907177
What this trial is testing

Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)

Who this might be right for
Multiple Sclerosis
Actelion 136
Not applicableStudy completedNCT05663853
What this trial is testing

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
LAPIX Therapeutics Inc. 137
Not applicableEnded earlyNCT03926637
What this trial is testing

Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 3,073
Not applicableStudy completedNCT05462678
What this trial is testing

Memory Rehabilitation Strategies in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
I.R.C.C.S. Fondazione Santa Lucia 60
Not applicableStudy completedNCT03138525
What this trial is testing

Immune Profiling During Ocrelizumab Treatment in Multiple Sclerosis

Who this might be right for
Multiple SclerosisHealthy
Brigham and Women's Hospital 161
Next Page